Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3

Pathum Thilakasiri, Ryan N. O’keefe, Sarah Q. To, David Chisanga, Moritz F. Eissmann, Annalisa L.E. Carli, Belinda Duscio, David Baloyan, Rhynelle S. Dmello, David Williams, John Mariadason, Ashleigh R. Poh, Bhupinder Pal, Benjamin T. Kile, Joseph H.A. Vissers, Kieran F. Harvey, Michael Buchert, Wei Shi, Matthias Ernst, Ashwini L. Chand

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Deregulation of the Hippo pathway is a driver for cancer progression and treatment resistance. In the context of gastric cancer, YAP1 is a biomarker for poor patient prognosis. Although genomic tumor profiling provides information of Hippo pathway activation, the present study demonstrates that inhibition of Yap1 activity has anti-tumor effects in gastric tumors driven by oncogenic mutations and inflammatory cytokines. We show that Yap1 is a key regulator of cell metabolism, proliferation, and immune responses in normal and neoplastic gastric epithelium. We propose that the Hippo pathway is targetable across gastric cancer subtypes and its therapeutic benefits are likely to be mediated by both cancer cell–intrinsic and –extrinsic mechanisms.

Original languageEnglish
Article numbere202302411
Number of pages17
JournalLife Science Alliance
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 2024

Cite this